Home / Dermatology
Dermatology
| 2 min read
Celgene will acquire Receptos for $232 per share, for a total deal value of approximately $7.2B
| 2 min read
The cash and equity transaction
adds KYBELLA, a treatment for double chin, to Allergan's portfolio
| 3 min read
NanoString, CITN to seek out biomarkers to predict outcomes for cancer immunotherapies
| 3 min read
Boehringer Ingelheim compound outperforms Stelara in head-to-head psoriasis study
| 3 min read
Liposuction
byproduct could cure erectile dysfunction, study suggests
| 2 min read
The companies will collaborate to advance Hanmi's HM71224
| 4 min read
A conversation with Nissim Mashiach, president
and CEO of the Israeli company Macrocure Ltd.
| 3 min read
Treatment of many types of pain
has relied on opioids, which bring their own set of problems. DDNews Managing Editor Lloyd Dunlap explores some of the progress that may mitigate such
problems
| 4 min read
Cara Therapeutics reports positive top-line data from Phase 1b trial of IV CR845 in
dialysis patients with uremic pruritus
| 4 min read
MIT
partnership with Massachusetts General Hospital, other institutions to foster regional ecosystem for rapidly evolving field
| 4 min read
RXi announces three months post scar revision surgery and the completion of
enrollment for its Phase 2a trial of RXI-109-1301
| 3 min read
Innate Pharma describes cutaneous T cell lymphoma
therapeutic in scientific journal Cancer Research
